![Babak Moghimi, MD](/sites/default/files/styles/1x1_sixth/public/thumbnails/image/CHLA-Babak-Moghimi-2.jpg.webp?itok=BdImOY16)
Babak Moghimi, MD
Dr. Babak Moghimi is the Section Head of Transplantation and Cellular Therapy at Children’s Hospital Los Angeles (CHLA) and a faculty member in the Department of Pediatrics at the University of Southern California. He earned his medical degree from Tehran University of Medical Sciences and completed his residency training in pediatrics at the University of Miami. He pursued a fellowship in pediatric hematology/oncology at the Children’s Hospital of Philadelphia, PA, and subsequently joined CHLA to complete advanced training in bone marrow transplantation and cell therapy.
Dr. Moghimi is a dedicated physician-scientist whose laboratory research focuses on developing novel and innovative cell therapy approaches to treat pediatric cancers. His lab has developed next-generation CAR-T cells designed to minimize toxicity while effectively targeting pediatric solid tumors and leukemias. Dr. Moghimi is a member of the Cell Therapy Program at USC, where he collaborates with colleagues to advance immunotherapies and contribute to groundbreaking developments in the field.
Education
Tehran University of Medical Sciences, Tehran, Iran
Shands Hospital/University of Florida, Gainesville – Pediatrics
Jackson Memorial Hospital, Miami – Pediatrics
Children’s Hospital of Philadelphia – Pediatric Hematology-Oncology
Children’s Hospital Los Angeles – Pediatric Bone Marrow Transplantation and Cell Therapy
Accomplishments
General Pediatrics, American Board of Pediatrics
Pediatric Hematology-Oncology, American Board of Pediatrics
American Association for Cancer Research (AACR)
American Society of Gene and Cell Therapy (ASGCT)
American Society of Hematology (ASH)
Children’s Oncology Group (COG)
Research
Research Interests:
- Tumor Microenvironment in Pediatric Solid Tumors
- Engineering Gated CAR-T Cells for Leukemia and Solid Tumors
- Non-viral Methods for CAR-T Cell Development
- TME-resistant CAR-T Cells for Pediatric solid tumors